Evidence map›Paper›PMID 25273069›Full record

ArticleGenome research2015

Shroom3 contributes to the maintenance of the glomerular filtration barrier integrity.

Nan Cher Yeo, Caitlin C O'Meara, Jason A Bonomo, Kerry N Veth, Ritu Tomar, Michael J Flister, Iain A Drummond, Donald W Bowden, Barry I Freedman, Jozef Lazar and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 7 syntheses or guidelines pooled it, 84 citations in OpenAlex.

  1. Genome-Wide Association Study for eGFR in a Taiwanese Population.Clinical journal of the American Society of Nephrology : CJASN · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Genome-wide association mapping and targeted loss of function studies identifyProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Review
  11. Article
  12. Mapping Shroom3 expression across the adult mouse.Gene expression patterns : GEP · 2025
    Article
  13. Article
  14. Article
  15. Clinical and Metabolic Signatures ofKidney international reports · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Nan Cher YeoHuman and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA; Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA;
Caitlin C O'MearaHuman and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA; Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA;
Jason A BonomoDepartment of Molecular Medicine and Translational Science, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, USA; Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, USA;
Kerry N VethDepartment of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA;
Ritu TomarNephrology Division, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA;
Michael J FlisterHuman and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA; Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA;
Iain A DrummondNephrology Division, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA; Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;
Donald W BowdenCenter for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, USA; Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, USA;
Barry I FreedmanCenter for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, USA; Department of Internal Medicine - Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, USA;
Jozef LazarHuman and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA; Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA;
Brian A LinkDepartment of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA;
Howard J JacobHuman and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA; Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA jacob@mcw.edu.
Medical College of Wisconsin · USWake Forest University · USHarvard University · USMassachusetts General Hospital · US

Funding

MORPHOLOGY MODULEP30EY001931 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI CARROLL, JOSEPH · 1985 to 2016
$9.8M
Physiological Genomics of Hypertensive Renal DiseaseR01HL069321 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LAZAR, JOZEF · 2001 to 2017
$5.6M
MAPPING GENES FOR NIDDM NEPHROPATHY IN AFRICAN AMERICANSR01DK053591 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BOWDEN, DONALD W · 1998 to 2015
$5.6M
Genetic Analysis of African American Hypertensive End-Stage Renal DiseaseR01DK070941 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FREEDMAN, BARRY IRA · 2006 to 2015
$4.7M
Subclinical CVD in African American Type 2 DiabeticsR01DK071891 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FREEDMAN, BARRY IRA · 2007 to 2016
$4.5M
Signaling and Gene Interactions Underlying Glaucoma Risk PhenotypesR01EY016060 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI LINK, BRIAN A · 2005 to 2015
$3.9M
Osr1 and Wnt signaling in nephrogenesis and kidney regenerationR01DK071041 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI DRUMMOND, IAIN A. · 2005 to 2014
$3.7M
Detection of Coding Variants Modulating Diabetic Nephropathy in African AmericansF30DK098836 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BONOMO, JASON ANDREW · 2013 to 2015
$135k
NEI NIH HHS P30 EY001931NEI NIH HHS R01 EY016060NHLBI NIH HHS R01 HL069321NHLBI NIH HHS R01HL069321NIDDK NIH HHS F30 DK098836NIDDK NIH HHS R01 DK053591NIDDK NIH HHS R01 DK070941NIDDK NIH HHS R01-DK070941NIDDK NIH HHS R01 DK071041NIDDK NIH HHS R01-DK071041NIDDK NIH HHS R01 DK071891NIDDK NIH HHS R01-DK071891NIDDK NIH HHS R01-DK53591
6 · The paper itself

Abstract

Genome-wide association studies (GWAS) identify regions of the genome correlated with disease risk but are restricted in their ability to identify the underlying causative mechanism(s). Thus, GWAS are useful "roadmaps" that require functional analysis to establish the genetic and mechanistic structure of a particular locus. Unfortunately, direct functional testing in humans is limited, demonstrating the need for complementary approaches. Here we used an integrated approach combining zebrafish, rat, and human data to interrogate the function of an established GWAS locus (SHROOM3) lacking prior functional support for chronic kidney disease (CKD). Congenic mapping and sequence analysis in rats suggested Shroom3 was a strong positional candidate gene. Transferring a 6.1-Mb region containing the wild-type Shroom3 gene significantly improved the kidney glomerular function in FHH (fawn-hooded hypertensive) rat. The wild-type Shroom3 allele, but not the FHH Shroom3 allele, rescued glomerular defects induced by knockdown of endogenous shroom3 in zebrafish, suggesting that the FHH Shroom3 allele is defective and likely contributes to renal injury in the FHH rat. We also show for the first time that variants disrupting the actin-binding domain of SHROOM3 may cause podocyte effacement and impairment of the glomerular filtration barrier.

Indexed as

AllelesAmino Acid SequenceAnimalsAnimals, CongenicAnimals, Genetically ModifiedCloning, MolecularExonsFemaleGenetic LociGenetic VariationGenome-Wide Association StudyGlomerular Filtration BarrierHumansKidney DiseasesMaleMicrofilament ProteinsMicrofilament ProteinsRNA, MessengerSHROOM3 protein, humanShroom3 protein, zebrafishZebrafish Proteins

Identifiers

PMID25273069
PMCPMC4317173
OpenAlexW2140095783

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.